Hera Biotech
Hera Biotech is a biotechnology company specializing in non-invasive, tissue-based diagnostics for women's health, focusing on endometriosis and cervical cancer detection. Their AI-powered platform includes MetriDx™, a non-surgical diagnostic tool for confirming and staging endometriosis, and HERAfem™, a real-time cervical cancer diagnostic device detecting CIN2+ lesions without biopsy. The company integrates advanced molecular and physical detection methods with adaptive AI/ML models, enabling faster, more accurate diagnoses in OB-GYN, fertility, and primary care settings. Hera Biotech aims to replace invasive, costly diagnostic procedures with accessible, point-of-care solutions, targeting global markets including Latin America, Asia, and Africa. With 8 patents, extensive clinical data, and partnerships with top clinics, Hera Biotech is positioned as a leader in AI-driven women's health diagnostics, addressing significant diagnostic delays and improving patient outcomes worldwide.
Hera Biotech
Hera Biotech is a biotechnology company specializing in non-invasive, tissue-based diagnostics for women's health, focusing on endometriosis and cervical cancer detection. Their AI-powered platform includes MetriDx™, a non-surgical diagnostic tool for confirming and staging endometriosis, and HERAfem™, a real-time cervical cancer diagnostic device detecting CIN2+ lesions without biopsy. The company integrates advanced molecular and physical detection methods with adaptive AI/ML models, enabling faster, more accurate diagnoses in OB-GYN, fertility, and primary care settings. Hera Biotech aims to replace invasive, costly diagnostic procedures with accessible, point-of-care solutions, targeting global markets including Latin America, Asia, and Africa. With 8 patents, extensive clinical data, and partnerships with top clinics, Hera Biotech is positioned as a leader in AI-driven women's health diagnostics, addressing significant diagnostic delays and improving patient outcomes worldwide.